This reduction in FFAR3, due to the intestinal dysbiosis characteristic of obesity, compromises the bacterial production of SCFA and its ability to activate this receptor, thus affecting energy homeostasis and the secretion of intestinal hormones such as PYY and GLP-1 [48]. This evidence concerns the gene FFAR3 and obesity disorder.